Disc Medicine to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 28, 2025
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at two upcoming investor conferences:
Read more at globenewswire.com
